Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 231, Issue 1, Pages 21-34
Publisher
Wiley
Online
2013-06-19
DOI
10.1002/path.4230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer
- (2013) Ali Bashashati et al. GENOME BIOLOGY
- LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin
- (2012) Prue A. Cowin et al. CANCER RESEARCH
- Mutational Processes Molding the Genomes of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- The Life History of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease
- (2012) Mauro Castellarin et al. JOURNAL OF PATHOLOGY
- BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
- (2012) Jessica N McAlpine et al. MODERN PATHOLOGY
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
- (2011) Elisabetta Kuhn et al. JOURNAL OF PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis
- (2010) Elisabetta Kuhn et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
- (2010) S. E. Baldus et al. CLINICAL CANCER RESEARCH
- Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer
- (2010) Julie M. Wu et al. HUMAN PATHOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
- (2010) S L Cooke et al. ONCOGENE
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
- (2008) Joshua Z Press et al. BMC CANCER
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
- (2008) Ann K. Folkins et al. GYNECOLOGIC ONCOLOGY
- The clonal evolution of metastases from primary serous epithelial ovarian cancers
- (2008) Lalarukh Khalique et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started